Cargando…

Influence of PM(1) exposure on total and cause-specific respiratory diseases: a systematic review and meta-analysis

An increasing number of studies examined the potential effects of PM(1) (submicronic particulate matter with an aerodynamic diameter ≤ 1 μm) on the risk of respiratory diseases; however, the results have been inconclusive. This study aimed to determine the overall association between PM(1) with tota...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yaoyu, Wu, Mengqiu, Li, Yutong, Liu, Xiangtong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810454/
https://www.ncbi.nlm.nih.gov/pubmed/34628607
http://dx.doi.org/10.1007/s11356-021-16536-0
Descripción
Sumario:An increasing number of studies examined the potential effects of PM(1) (submicronic particulate matter with an aerodynamic diameter ≤ 1 μm) on the risk of respiratory diseases; however, the results have been inconclusive. This study aimed to determine the overall association between PM(1) with total and cause-specific respiratory diseases. A systematic review and meta-analysis was conducted with 68 related articles retrieved, and six articles met the full inclusion criteria for the final analysis. For a 10 μg/m(3) increase in PM(1), the pooled odds ratio (OR) was 1.05 (95% CI 0.98–1.12) for total respiratory diseases, 1.25 (95% CI 1.00–1.56) for asthma, and 1.07 (95% CI 1.04–1.10) for pneumonia with the I(2) value of 87%, 70%, and 0%, respectively. Subgroup analyses showed that long-term exposure to PM(1) was associated with increased risk of asthma (OR 1.47, 95% CI 1.33–1.63) with an I(2) value of 0%, while short-term exposure to PM(1) was not associated with asthma (OR 1.07, 95% CI 0.89–1.27) with the I(2) value of 0%. Egger’s test showed that publication bias existed (P = 0.041); however, the funnel plot was symmetrical with the inclusion of the moderator. In conclusion, elevated levels of PM(1) may increase morbidity in total and cause-specific respiratory diseases in the population. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11356-021-16536-0.